*Some Market data delayed by 15 mins.

Pasithea Therapeutics Corp. Common Stock

Symbol: KTTA (NASDAQ)
0.72 ▲ (1.00%) 0.007

Company Description:
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Key Stats
  • Today's Open: $0.71
  • Today's High: $0.751
  • Today's Low: $0.657
  • Today's Volume: 68.52K
  • Yesterday Close: $0.7099
  • Yesterday High: $0.735
  • Yesterday Low: $0.7
  • Yesterday Volume: 32.21K
  • Last Min Volume: 100
  • Last Min High: $0.717
  • Last Min Low: $0.717
  • Last Min VWAP: $0.717
Company Profile
  • Name: Pasithea Therapeutics Corp. Common Stock
  • Website: https://www.pasithea.com
  • Listed Date: 2021-09-15
  • Location: MIAMI BEACH, FL
  • Market Status: Active
  • CIK Number: 0001841330
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $5.28M
  • Round Lot: 100
  • Outstanding Shares: 7.44M
  • Asset Type: CS
RECENT FILINGS FOR KTTA
Filing Date Filing Type Format
2025-09-16 8-K View
2025-09-09 S-8 View
2025-09-03 8-K View
2025-08-14 10-Q View
2025-08-14 SCHEDULE 13G/A View
2025-07-24 ARS View
2025-07-24 DEF 14A View
2025-07-14 PRE 14A View
2025-07-11 8-K View
2025-06-27 8-K View
2025-06-20 8-K View
2025-06-20 424B5 View
2025-05-15 10-Q View
2025-05-15 SCHEDULE 13G/A View
2025-05-14 144 View
2025-05-14 4 View
2025-05-12 SCHEDULE 13G View
2025-05-12 SCHEDULE 13G View
2025-05-09 SCHEDULE 13G/A View
2025-05-09 SCHEDULE 13G View
Latest News on KTTA

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.